{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:05:12Z","timestamp":1793657112332,"version":"4.5.1"},"reference-count":57,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2004,6,4]],"date-time":"2004-06-04T00:00:00Z","timestamp":1086307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100010029","name":"Lancaster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Convergent biochemical and genetic evidence suggests that the formation of \u03b1\u2010synuclein (\u03b1\u2010syn) protein deposits is an important and, probably, seminal step in the development of Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). It has been reported that transgenic animals overexpressing human \u03b1\u2010syn develop lesions similar to those found in the brain in PD, together with a progressive loss of dopaminergic cells and associated abnormalities of motor function. Inhibiting and\/or reversing \u03b1\u2010syn self\u2010aggregation could, therefore, provide a novel approach to treating the underlying cause of these diseases. We synthesized a library of overlapping 7\u2010mer peptides spanning the entire \u03b1\u2010syn sequence, and identified amino acid residues 64\u2012100 of \u03b1\u2010syn as the binding region responsible for its self\u2010 association. Modified short peptides containing \u03b1\u2010syn amino acid sequences from part of this binding region (residues 69\u201272), named \u03b1\u2010syn inhibitors (ASI), were found to interact with full\u2010 length \u03b1\u2010syn and block its assembly into both early oligomers and mature amyloid\u2010like fibrils. We also developed a cell\u2010permeable inhibitor of \u03b1\u2010syn aggregation (ASID), using the polyarginine peptide delivery system. This ASID peptide was able to inhibit the DNA damage induced by Fe(II) in neuronal cells transfected with \u03b1\u2010syn(A53T), a familial PD\u2010associated mutation. ASI peptides without this delivery system did not reverse levels of Fe(II)\u2010induced DNA damage. Furthermore, the ASID peptide increased (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.0005) the number of cells stained positive for Bcl\u20102, while significantly (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.05) decreasing the percentage of cells stained positive for BAX. These short peptides could serve as lead compounds for the design of peptidomimetic drugs to treat PD and related disorders.\n                  <\/jats:p>","DOI":"10.1096\/fj.03-1346fje","type":"journal-article","created":{"date-parts":[[2004,6,7]],"date-time":"2004-06-07T21:01:39Z","timestamp":1086642099000},"page":"1315-1317","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["A strategy for designing inhibitors of \u03b1 \u2010synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders"],"prefix":"10.1096","volume":"18","author":[{"given":"Omar M. A.","family":"El-Agnaf","sequence":"first","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina E.","family":"Paleologou","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Greer","sequence":"additional","affiliation":[{"name":"School of Biology and Biochemistry The Queen's University of Belfast Belfast BT9 7BL United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmawala M.","family":"Abogrein","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan A.","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Fullwood","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E.","family":"Benson","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie J.","family":"Ford","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Harriott","sequence":"additional","affiliation":[{"name":"School of Biology and Biochemistry The Queen's University of Belfast Belfast BT9 7BL United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Cookson","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics National Institute on Aging Bethesda Maryland 20892 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allsop","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences Lancaster University Lancaster LA1 4YQ United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,6,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6469"},{"key":"e_1_2_6_3_1","first-page":"879","article-title":"Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba M.","year":"1998","journal-title":"Am. J. Pathol."},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda K.","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S.A."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2045"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0298-106"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00504-7"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79256-4"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/35081564"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5456.1265"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/35006074"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1007"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/jsbi.2000.4262"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00481-2"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/416507a"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/416535a"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2001.4743"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6448"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.2.571"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01419-7"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.14.9843"},{"key":"e_1_2_6_22_1","first-page":"19","article-title":"\u03b1- Synuclein fibrillogenesis is nucleation-dependent: Implications for the pathogenesis of Parkinson's disease","volume":"274","author":"Wood S. J.","year":"1999","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01418-5"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.9.4897"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1413"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.15.8545"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)11419-3"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5783"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2001.5244"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"\u03b2-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy","volume":"7","author":"Soto C.","year":"1998","journal-title":"Nat. Med."},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1096\/fj.01-0841fje","article-title":"Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with \u03b2-sheet breaker peptide","volume":"8","author":"Permanne B.","year":"2002","journal-title":"FASEB J."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg144"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3051"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0098fje"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)01125-X"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/17.4.345"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.02013.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh048"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3230539"},{"key":"e_1_2_6_40_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1074\/jbc.M002413200","article-title":"Wild-type but not Parkinson's disease- related Ala-53 to Thr mutant \u03b1-synuclein protects neuronal cells from apoptotic stimuli","volume":"275","author":"Costa C. A.","year":"2000","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"50980","DOI":"10.1074\/jbc.M207825200","article-title":"\u03b1-Synuclein lowers p53- dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease","volume":"277","author":"Costa C. A.","year":"2002","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00149.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000"},{"key":"e_1_2_6_44_1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine- dependent neurotoxicity of \u03b1-synuclein: A mechanism for selective neurodegeneration in Parkinson disease","volume":"6","author":"Xu J.","year":"2002","journal-title":"Nat. Med."},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M007540200"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.24.13003"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.151247498"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.2741\/wu1"},{"key":"e_1_2_6_49_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1073\/pnas.1936213100","article-title":"Control of Bcl-2 expression by reactive oxygen species","volume":"100","author":"Hildeman D. A.","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S.A."},{"key":"e_1_2_6_50_1","first-page":"1826","article-title":"\u03b1-Synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt kinase pathway","volume":"16","author":"Seo J. H.","year":"2002","journal-title":"FASEB J."},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00513-5"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(02)00801-8"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008919200"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi034028"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi002416v"},{"key":"e_1_2_6_56_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1074\/jbc.271.47.29525","article-title":"A strategy for designing inhibitors of \u03b2-amyloid toxicity","volume":"271","author":"Ghanta J.","year":"1996","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5433.1569"},{"key":"e_1_2_6_58_1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm994","article-title":"A new cell-permeable peptide allows successful allogeneic islet transplantation in mice","volume":"3","author":"Noguchi H.","year":"2004","journal-title":"Nat. Med."}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.03-1346fje","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.03-1346fje","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.03-1346fje","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:22:52Z","timestamp":1761700972000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.03-1346fje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,4]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1096\/fj.03-1346fje"],"URL":"https:\/\/doi.org\/10.1096\/fj.03-1346fje","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,4]]},"assertion":[{"value":"2003-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}